Playback speed
10 seconds
Overview of Current Therapeutic Options in AML of Young Adults: New Drugs Like Venetoclax, Midostaurin, or Enasidenib Have Transformed the Paradigm of Treatment
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Mehmet Yilmaz
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Mehmet Yilmaz
180 views
December 20, 2019
Login to view comments.
Click here to Login